DWTX Stock Summary and Trading Ideas (Dogwood Therapeutics | NASDAQ:DWTX)

Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Dogwood Therapeutics trades on the NASDAQ stock market under the symbol DWTX.

As of March 5, 2025, DWTX stock price climbed to $4.45 with 27,861 million shares trading.

DWTX has a beta of 4.10, meaning it tends to be more sensitive to market movements. DWTX has a correlation of 0.03 to the broad based SPY ETF.

DWTX has a market cap of $5.93 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that DWTX belongs to (by Net Assets): VXF.

DWTX support price is $3.75 and resistance is $4.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DWTX shares will trade within this expected range on the day.